Saturday, October 24, 2026Daily EditionIndependent journalism
BeCrypto NewsIndependent digital asset reporting
Sign in Write
BTC $80,485 −1.10%ETH $2,345.26 −2.31%SOL $101.45 −2.29%XRP $1.29 −1.37%BNB $732.12 −1.34%DOGE $0.0773 −2.47%Prices: CoinGecko,
Back
Markets

Pfizer Candidate Shows Immune Response Across 25 Serotypes in Phase 2

By John Kim for TokenPost

Image: TokenPost

A four-dose series of PF-07872412 was evaluated, with safety and tolerability also reported.

Read the full story on TokenPost

BeCrypto News shows a short excerpt and links to the publisher. The full report belongs to TokenPost.

Latest in Markets

All Markets stories